Form 4: Pediatrix Medical Group CEO Acquires 640,000 Performance Share Units

Mark S. Ordan, CEO of Pediatrix Medical Group, acquired 640,000 performance share units (PSUs) on January 12, 2025, which will vest based on service and stock price performance.

Summary

• Mark S. Ordan, the Chief Executive Officer of Pediatrix Medical Group, Inc., acquired 640,000 Performance Share Units (PSUs) on January 12, 2025.
• Each PSU represents a contingent right to receive one share of Pediatrix Medical Group's common stock upon vesting.
• The PSUs vest upon the satisfaction of both a service-based and a performance-based condition.
• The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date.
• Shares underlying the PSUs are earned in one-third installments based on the Issuer achieving stock price hurdles equal to 125%, 150% and 175% of $13.55 for at least 20 consecutive trading days before the third anniversary of the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices and aligns management incentives with shareholder value through performance-based vesting.

Positives

• The acquisition of performance share units by the CEO aligns his interests with those of the shareholders, as the units vest based on the company's stock price performance.

Risks

• The vesting of the PSUs is contingent on the company achieving specific stock price targets, which may not be met.

Future Outlook

The vesting of the PSUs is tied to the future stock price performance of Pediatrix Medical Group, indicating an expectation of growth.

Industry Context

This type of equity compensation is common in the healthcare industry to incentivize executives and align their interests with shareholders.

Stakeholder Impact

• Shareholders may view the acquisition of performance share units by the CEO positively, as it aligns his interests with the company's stock price performance.

Key Dates